As Robert F. Kennedy Jr. considers significant changes to the U.S. Preventive Services Task Force (USPSTF), various medical organizations, including the American Medical Association (AMA), have expressed deep concerns. Reports suggest that Kennedy may dismiss the current advisory panel responsible for crucial preventive health services, including cancer screenings and HIV prevention drugs. The AMA president has warned that such cuts could jeopardize essential preventive services that benefit millions of Americans. In response to these plans, medical groups are urging Kennedy to retain the task force, emphasizing the importance of maintaining robust health screenings. The potential overhaul has sparked a significant debate, with critics arguing that dismantling the panel would be detrimental to public health and research.